Earnings call transcript: cbdMD Q3 2025 earnings miss drives stock down

cbdMD Inc. (YCBD) reported a challenging Q3 2025, with revenue of $4.61 million missing forecasts by 15.72% and an EPS of -$0.21, leading to a 16.9% stock price decline. The miss was attributed to increased regulatory scrutiny in the CBD/hemp markets and significant sales declines across e-commerce and wholesale channels. Despite these headwinds, the company is pursuing growth through its Oasis brand expansion and cost-cutting initiatives, which have notably reduced year-to-date net losses, with InvestingPro highlighting a low revenue valuation multiple and potential upside if strategic execution navigates the uncertain regulatory landscape.

Analysis

cbdMD Inc. (YCBD) reported a challenging third quarter for fiscal 2025, with revenue of $4.61 million missing consensus estimates by 15.72% and an earnings per share of -$0.21. This shortfall triggered a significant negative market reaction, causing the stock to fall 16.9%. The revenue decline was broad, with e-commerce sales down 7.7% and wholesale sales dropping 17.1% year-over-year, a disruption management attributes largely to a volatile state-level regulatory environment creating uncertainty for partners. Despite these top-line pressures, the company maintained a healthy gross profit margin of 61% and demonstrated operational progress by reducing its year-to-date net loss to $1.3 million from $3.5 million in the prior year. The strategic pivot towards the 'Oasis' hemp-derived beverage brand is the central pillar of its growth narrative, with distribution expanding into a seventh state. However, management noted that Oasis carries a lower gross margin than the legacy CBD business, which may temper overall profitability as it scales. Financially, the company holds $1.1 million in cash, and while the balance sheet is cleaner following the elimination of preferred dividend obligations, continued investment in inventory and marketing contributed to a non-GAAP adjusted EBITDA loss of $624,000 for the quarter. The stock is currently trading near its 52-week low and is described as being in oversold territory with a low revenue valuation multiple, presenting a classic high-risk, high-reward scenario contingent on successful strategic execution.

Key Decisions for Investors

• Investors should weigh the significant execution risk stemming from regulatory headwinds and declining legacy sales against the stock's low revenue valuation multiple and the high-growth potential of the Oasis brand.
• Closely monitor the progress of the Oasis brand expansion and any management disclosures on its revenue contribution, as its success is critical to reversing the company's overall sales decline and achieving profitability.
• Pay close attention to wholesale channel performance and management commentary on the regulatory landscape in the coming quarters, as stabilization in this segment is key to meeting future revenue targets.
• Given the $1.1 million cash position and quarterly EBITDA loss, scrutinize the company's cash burn rate and path to operational breakeven, as further capital may be needed to fund its growth ambitions.